To test the cytotoxic activity of RevCAR T cells redirected by the novel Fn14-specific RevTMs, we evaluated the specific lysis of the GBM cells by using a luminescence-based cytotoxicity assay. This evidence concerns the gene TNFRSF12A and glioblastoma.